NFA
AVNR

Nationwide Fund Advisors’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Nationwide Fund Advisors’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-146,414
Closed -$2.48M – 3397
2014
Q4 		$2.48M Buy
146,414
+15,235
+12% +$214K 0.01% 1304
2014
Q3 		$1.56M Buy
131,179
+7,537
+6% +$51.5K 0.01% 1577
2014
Q2 		$697K Buy
123,642
+11,560
+10% +$53.3K ﹤0.01% 2073
2014
Q1 		$411K Sell
112,082
-53
-0% -$202 ﹤0.01% 2146
2013
Q4 		$377K Sell
112,135
-3,534
-3% -$14.6K ﹤0.01% 2368
2013
Q3 		$490K Buy
115,669
+6,638
+6% +$31.5K ﹤0.01% 2227
2013
Q2 		$502K Buy
+109,031
New +$375K ﹤0.01% 2015

Nationwide Fund Advisors's AVNR Position: Q1 2015 in Review

Nationwide Fund Advisors sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 146,414 shares — an estimated $2.48M sold.

Nationwide Fund Advisors first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $2.48M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Nationwide Fund Advisors reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Nationwide Fund Advisors sold 146,414 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $2.48M.
  • Nationwide Fund Advisors first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Nationwide Fund Advisors's AVANIR PHARMACEUTICALS, INC CL A position peaked at $2.48M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Nationwide Fund Advisors's 13F filing for Q1 2015, filed 5 May 2015.